Risk Factors and Potential Protective Medications for Parkinson Disease
Risk Factors and Potential Protective Medications for Parkinson Disease
批准号:
8259688
负责人:
DAVID W. SPARROW
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-10-01 至 2013-03-31
关键词:
3-hydroxy-3-methylglutaryl-coenzyme AAddressAnti-Inflammatory AgentsAnti-inflammatoryAntihypertensive AgentsBody mass indexCalcium Channel BlockersCaringChemicalsCholesterolDataDevelopmentDiabetes MellitusDisease AssociationDoseDrug usageEpidemiologic StudiesEpidemiologyExposure toFrequenciesHealthHerbicidesIndividualInvestigationLightLipidsLocationLong-Term EffectsMedicalMedical RecordsMethodologyMissionModelingModificationNon-Steroidal Anti-Inflammatory AgentsOxidoreductaseParkinson DiseasePharmaceutical PreparationsPharmacy facilityPopulationProphylactic treatmentRecordsResearchRiskRisk FactorsRoleSeriesSerumSmokingSourceSystemVeteransVietnamWaragent orangebasecase controlcombatfollow-uphigh riskimprovedindexinginhibitor/antagonistinnovationprospectivepublic health relevanceresearch studyresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
We propose to assess whether the risk of Parkinson's disease (PD) among veterans of the Vietnam War is
predicted by exposure to herbicides, lower cholesterol, diabetes, higher body mass index (BMI), and use of
statins (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors), non-steroidal anti-inflammatory drugs
(NSAIDs), and anti-hypertensive medications. If particular medications reduce the risk of PD, then they could
potentially be considered as a prophylactic treatment against PD among veterans known or suspected to be at
higher risk of PD. The proposed investigation will take advantage of access to a population of an estimated
3.2 million Vietnam veterans. This population is uniquely suited to address the question of the specific
involvement of herbicides in PD because of their wide exposure to herbicides at levels much higher than in any
other population in which this question has been studied, and the existence of a sophisticated exposure
assessment model based on troop location information. In addition, the detailed medical and pharmacy
records in a population as large as that of Vietnam veterans will allow for some of the strongest, least biased
results to date on the role of several different medical conditions and medications, while providing sufficient
power to explore dose-response relations and other subanalyses. We will identify PD cases and controls
through VA medical records and randomly select 700 cases and 1,400 controls.
Hypothesis 1: Higher exposure to Agent Orange and other herbicides is associated with increased risk of PD.
Hypothesis 2A: Higher cholesterol levels are associated with a decreased risk of PD.
Hypotheses 2B: Diabetes is associated with an increased risk of PD.
Hypothesis 2C: Higher BMI is associated with an increased risk of PD.
Hypothesis 3A: Statin use is associated with a decreased risk of PD.
Hypothesis 3B: NSAID use is associated with a decreased risk of PD.
Hypothesis 3C: Calcium channel blocker use is associated with a decreased risk of PD.
As an exploratory aim, we will also examine possible effect modification of the herbicide-PD association by the
medical conditions and medication use variables examined in Hypotheses #2 and #3, as well as by smoking.
In light of the very high levels of herbicide exposure among Vietnam veterans and the frequency of the risk
conditions of hypotheses 2A-2C among this population, understanding the relation of such exposures to a
debilitating illness such as PD is highly relevant to the VA mission of caring for our combat veterans.
Furthermore, if it can be shown that any of the medications we will examine reduce risk of PD or modifies risk
attributable to herbicide exposure, then these medications could potentially be considered as a prophylactic
treatment against PD among veterans known or suspected to have been exposed to herbicides.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Telemedicine intervention in patients with chronic pain in PD
-
批准号:10532427
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:DAVID W. SPARROW
-
依托单位:
An RCT of a telemedicine intervention for hypokinetic dysarthria in PD
-
批准号:10391336
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:DAVID W. SPARROW
-
依托单位:
An RCT of a telemedicine intervention for hypokinetic dysarthria in PD
-
批准号:10172319
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:DAVID W. SPARROW
-
依托单位:
An RCT of a telemedicine intervention for hypokinetic dysarthria in PD
-
批准号:10642681
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:DAVID W. SPARROW
-
依托单位:
Exercise training to improve cognitive function_523_Sparrow
-
批准号:9910068
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:DAVID W. SPARROW
-
依托单位:
Highly challenging balance program to reduce fall rate in PD
-
批准号:10201779
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:DAVID W. SPARROW
-
依托单位:
Highly challenging balance program to reduce fall rate in PD
-
批准号:10436875
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:DAVID W. SPARROW
-
依托单位:
Telephone-linked, home-based exercise training in PD
-
批准号:9235736
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:DAVID W. SPARROW
-
依托单位:
A telemedicine intervention to improve physical function in patients with PD
-
批准号:8695116
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:DAVID W. SPARROW
-
依托单位:
A telemedicine intervention to improve physical function in patients with PD
-
批准号:8392810
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:DAVID W. SPARROW
-
依托单位:
An RCT of telemedicine interventions for OSA
-
批准号:8182124
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:DAVID W. SPARROW
-
依托单位:
An RCT of telemedicine interventions for OSA
-
批准号:8600168
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:DAVID W. SPARROW
-
依托单位:
An RCT of telemedicine interventions for OSA
-
批准号:7868558
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:DAVID W. SPARROW
-
依托单位:
Risk Factors and Potential Protective Medications for Parkinson Disease
-
批准号:8195957
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:DAVID W. SPARROW
-
依托单位:
Risk Factors and Potential Protective Medications for Parkinson Disease
-
批准号:7795565
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:DAVID W. SPARROW
-
依托单位:
Risk Factors and Potential Protective Medications for Parkinson Disease
-
批准号:7913052
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:DAVID W. SPARROW
-
依托单位:
ANXIETY AND CARDIOVASCULAR AUTONOMIC CONTROL
-
批准号:2872915
-
项目类别:
-
资助金额:$23.46万
-
财政年份:1996
-
负责人:DAVID W. SPARROW
-
依托单位:
ANXIETY AND CARDIOVASCULAR AUTONOMIC CONTROL
-
批准号:2232326
-
项目类别:
-
资助金额:$21.72万
-
财政年份:1996
-
负责人:DAVID W. SPARROW
-
依托单位:
ANXIETY AND CARDIOVASCULAR AUTONOMIC CONTROL
-
批准号:2460115
-
项目类别:
-
资助金额:$19.17万
-
财政年份:1996
-
负责人:DAVID W. SPARROW
-
依托单位:
IMPACT OF SLEEP DISORDERED BREATHING IN OLDER ADULTS
-
批准号:2227490
-
项目类别:
-
资助金额:$19.91万
-
财政年份:1994
-
负责人:DAVID W. SPARROW
-
依托单位:
海外基金